Consolidated Balance Sheet (IFRS)

in € Note 12/31/2016 12/31/2015
ASSETS
Current Assets
Cash and Cash Equivalents 2.8.1, 5.1 73,928,661 90,927,673
Available-for-sale Financial Assets 2.8.1, 5.2 63,361,727 64,292,830
Bonds, Available-for-sale 2.8.1, 5.2 6,532,060 33,120,117
Financial Assets classified as Loans and Receivables 2.8.1, 5.2 136,108,749 94,587,528
Accounts Receivable 2.8.2, 5.3 12,596,655 11,442,059
Tax Receivables 2.8.2, 5.5 519,915 826,102
Other Receivables 2.8.2, 5.4 656,887 1,324,236
Inventories, Net 2.8.3, 5.5 310,366 368,782
Prepaid Expenses and Other Current Assets 2.8.4, 5.5 14,041,469 3,227,008
Total Current Assets 308,056,489 300,116,335
Non-current Assets
Property, Plant and Equipment, Net 2.8.5, 5.6 4,189,108 3,474,018
Patents, Net 2.8.6, 5.7.1 5,323,341 6,141,061
Licenses, Net 2.8.6, 5.7.2 3,146,937 3,244,800
In-process R&D Programs 2.8.6, 5.7.3 50,818,700 60,959,887
Software, Net 2.8.6, 5.7.4 1,285,474 1,936,268
Goodwill 2.8.6, 5.7.5 7,364,802 7,364,802
Financial Assets classified as Loans and Receivables, Net of Current Portion 2.8.1, 5.2 79,521,181 15,510,989
Deferred Tax Asset 2.9.6, 4.4 0 381,949
Prepaid Expenses and Other Assets, Net of Current Portion 2.8.7, 5.8 3,894,085 949,381
Total Non-current Assets 155,543,628 99,963,155
Total Assets 463,600,117 400,079,490
in € Note 12/31/2016 12/31/2015
LIABILITIES AND STOCKHOLDERS’ EQUITY    
Current Liabilities    
Accounts Payable and Accrued Expenses 2.9.1, 6.1 32,222,616 22,341,663
Tax Provisions 2.9.2, 6.2 1,652,006 1,698,276
Provisions 2.9.1, 6.2 3,195,252 1,436,384
Current Portion of Deferred Revenue 2.9.3, 6.3 1,232,072 1,994,120
Total Current Liabilities   38,301,946 27,470,443
Non-current Liabilities    
Provisions, Net of Current Portion 2.9.1, 6.2 23,166 43,344
Deferred Revenue, Net of Current Portion 2.9.4, 6.3 1,672,872 2,512,666
Convertible Bonds due to Related Parties 2.9.5 218,293 225,000
Deferred Tax Liability 2.9.6, 4.4 7,421,835 7,092,030
Other Liabilities, Net of Current Portion 2.9.7, 6.4 501,840 0
Total Non-current Liabilities   9,838,006 9,873,040
Total Liabilities   48,139,952 37,343,483
   
Stockholders’ Equity    
Common Stock 2.9.8, 6.5.1 29,159,770 26,537,682
Ordinary Shares Issued (29,159,770 and 26,537,682 for 2016 and 2015, respectively)    
Ordinary Shares Outstanding (28,763,760 and 26,103,012 for 2016 and 2015, respectively)    
Treasury Stock (396,010 and 434,670 shares for 2016 and 2015, respectively), at Cost 2.9.8, 6.5.4 (14,648,212) (15,827,946)
Additional Paid-in Capital 2.9.8, 6.5.5 428,361,175 319,394,322
Revaluation Reserve 2.9.8, 6.5.6 136,101 (202,158)
Accumulated Income/(Deficit) 2.9.8, 6.5.7 (27,548,669) 32,834,107
Total Stockholders’ Equity   415,460,165 362,736,007
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY   463,600,117 400,079,490
arrow-topCreated with sketchtool.Top arrow-leftCreated with sketchtool.Consolidated Statement of Comprehensive Income (IFRS)